207 related articles for article (PubMed ID: 3057985)
21. Extranodal non-Hodgkin lymphoma of the sinonasal cavities: A 22-case report.
Lombard M; Michel G; Rives P; Moreau A; Espitalier F; Malard O
Eur Ann Otorhinolaryngol Head Neck Dis; 2015 Nov; 132(5):271-4. PubMed ID: 26363601
[TBL] [Abstract][Full Text] [Related]
22. Bone marrow involvement and the prognosis of low grade non-Hodgkin's lymphoma.
Zemunik T; Vucković J; Marinković M; Forempoher G
Croat Med J; 1998 Dec; 39(4):419-21. PubMed ID: 9841943
[TBL] [Abstract][Full Text] [Related]
23. Non-Hodgkin's lymphomas: characteristics of long-term survivors following conservative treatment.
Straus DJ; Gaynor JJ; Leiberman PH; Filippa DA; Koziner B; Clarkson BD
Am J Med; 1987 Feb; 82(2):247-56. PubMed ID: 3812517
[TBL] [Abstract][Full Text] [Related]
24. Non-Hodgkin lymphoma: diagnosis and treatment.
Ansell SM; Armitage J
Mayo Clin Proc; 2005 Aug; 80(8):1087-97. PubMed ID: 16092591
[TBL] [Abstract][Full Text] [Related]
25. Risk classification as the basis for clinical staging of diffuse large-cell lymphoma derived from 10-year survival data.
Velasquez WS; Jagannath S; Tucker SL; Fuller LM; North LB; Redman JR; Swan F; Hagemeister FB; McLaughlin P; Cabanillas F
Blood; 1989 Aug; 74(2):551-7. PubMed ID: 2752132
[TBL] [Abstract][Full Text] [Related]
26. [Serum ferritin--a tumor marker in malignant lymphomas?].
Aulbert E; Steffens O
Onkologie; 1990 Apr; 13(2):102-8. PubMed ID: 2197581
[TBL] [Abstract][Full Text] [Related]
27. [Clinical and prognostic relevance of the Kiel classification of non-Hodgkin lymphomas].
Brittinger G; Bartels H; Common H; Dühmke E; Engelhard M; Fülle HH; Gunzer U; Gyenes T; Heinz R; König E
Onkologie; 1986 Apr; 9(2):118-25. PubMed ID: 3520420
[TBL] [Abstract][Full Text] [Related]
28. Lymphoma of the Eyelid - An International Multicenter Retrospective Study.
Svendsen FH; Rasmussen PK; Coupland SE; Esmaeli B; Finger PT; Graue GF; Grossniklaus HE; Honavar SG; Khong JJ; McKelvie PA; Mulay K; Ralfkiaer E; Sjö LD; Vemuganti GK; Thuro BA; Curtin J; Heegaard S
Am J Ophthalmol; 2017 May; 177():58-68. PubMed ID: 28209503
[TBL] [Abstract][Full Text] [Related]
29. Is radiotherapy curative for stage I and II low-grade follicular lymphoma? Results of a long-term follow-up study of patients treated at Stanford University.
Mac Manus MP; Hoppe RT
J Clin Oncol; 1996 Apr; 14(4):1282-90. PubMed ID: 8648385
[TBL] [Abstract][Full Text] [Related]
30. [Prognostic factors in low-grade lymphoma].
Gandarillas MA; Conde E; Mazorra F; Cuadrado MA; Baro J; Garijo J; Recio M; Richard C; Iriondo A; Zubizarreta A
Sangre (Barc); 1998 Jun; 43(3):185-90. PubMed ID: 9741223
[TBL] [Abstract][Full Text] [Related]
31. [Value of the Kiel morphological classification in the clinical aspects of non-Hodgkin's lymphoma].
Glińska H; Papla B; Siuda M; Zulichowska J
Przegl Lek; 1989; 46(11):757-61. PubMed ID: 2623182
[TBL] [Abstract][Full Text] [Related]
32. Fludarabine and mitoxantrone followed by yttrium-90 ibritumomab tiuxetan in previously untreated patients with follicular non-Hodgkin lymphoma trial: a phase II non-randomised trial (FLUMIZ).
Zinzani PL; Tani M; Pulsoni A; Gobbi M; Perotti A; De Luca S; Fabbri A; Zaccaria A; Voso MT; Fattori P; Guardigni L; Ronconi S; Cabras MG; Rigacci L; De Renzo A; Marchi E; Stefoni V; Fina M; Pellegrini C; Musuraca G; Derenzini E; Pileri S; Fanti S; Piccaluga PP; Baccarani M
Lancet Oncol; 2008 Apr; 9(4):352-8. PubMed ID: 18342572
[TBL] [Abstract][Full Text] [Related]
33. [Prognostic factors in Hodgkin and non-Hodgkin lymphomas].
Cuenca X; Xhaard A; Mounier N
Bull Cancer; 2009 Apr; 96(4):461-73. PubMed ID: 19357020
[TBL] [Abstract][Full Text] [Related]
34. Prognostic factors in high and intermediate grade non-Hodgkin's lymphoma.
Cowan RA; Jones M; Harris M; Steward WP; Radford JA; Wagstaff J; Deakin DP; Crowther D
Br J Cancer; 1989 Feb; 59(2):276-82. PubMed ID: 2930692
[TBL] [Abstract][Full Text] [Related]
35. [Treatment outcome in primary testicular non-Hodgkin lymphoma].
Iványi JL; Marton E; Plander M; Engert ZV; Tóth C
Orv Hetil; 2013 Oct; 154(42):1666-73. PubMed ID: 24121219
[TBL] [Abstract][Full Text] [Related]
36. Prognostic factors in aggressive malignant lymphomas: description and validation of a prognostic index that could identify patients requiring a more intensive therapy. The Groupe d'Etudes des Lymphomes Agressifs.
Coiffier B; Gisselbrecht C; Vose JM; Tilly H; Herbrecht R; Bosly A; Armitage JO
J Clin Oncol; 1991 Feb; 9(2):211-9. PubMed ID: 1703226
[TBL] [Abstract][Full Text] [Related]
37. Primary non-Hodgkin lymphoma of the breast: The Mayo Clinic Experience.
Wong WW; Schild SE; Halyard MY; Schomberg PJ
J Surg Oncol; 2002 May; 80(1):19-25; discussion 26. PubMed ID: 11967901
[TBL] [Abstract][Full Text] [Related]
38. The follicular non-Hodgkin's lymphomas--II. Prognostic factors: what do they mean?
Denham JW; Denham E; Dear KB; Hudson GV
Eur J Cancer; 1996 Mar; 32A(3):480-90. PubMed ID: 8814696
[TBL] [Abstract][Full Text] [Related]
39. Non-hodgkin's lymphomas in Saskatchewan: a clinicopathologic study.
Cherian T; Skinnider LF; Wright JL; Komjathy G
Can Med Assoc J; 1978 Sep; 119(5):435-41. PubMed ID: 356951
[TBL] [Abstract][Full Text] [Related]
40. A review of histology of bone marrow trephine in malignant lymphomas.
Durosinmi MA; Mabayoje VO; Akinola NO
Niger J Med; 2003; 12(4):198-201. PubMed ID: 14768193
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
